EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
Turnover
42.86%
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
-7.64%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
-$816M
(-13%)
Cap. Flow
-$82.7M
Cap. Flow
% of AUM
-1.56%
Top 10 Holdings %
Top 10 Hldgs %
17.57%
Holding
743
New
97
Increased
366
Reduced
207
Closed
70
Avg Time Held
1.7
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VALT
ETFMG Sit Ultra Short ETF
VALT
|
+$49.8M |
| 2 |
N-able
NABL
|
+$49.3M |
| 3 |
SentinelOne
S
|
+$26.5M |
| 4 |
BlackBerry
BB
|
+$23M |
| 5 |
Marqeta
MQ
|
+$21.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$53.4M |
| 2 |
PFPT
Proofpoint, Inc.
PFPT
|
+$50.7M |
| 3 |
Turning Point Brands
TPB
|
+$45.7M |
| 4 |
MAG
MAG Silver
MAG
|
+$29.1M |
| 5 |
GrowGeneration
GRWG
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 47.43% |
| 2 | Materials | 12.97% |
| 3 | Healthcare | 12.03% |
| 4 | Financials | 8.36% |
| 5 | Miscellaneous | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Goldgroup Mining
GORO
$543M
| $1.21M | 0.02% |
193,576
+2,851
| +1% | +$21.7K |
2018 Q2
13 quarters
|
|
252
AudioCodes
AUDC
$272M
| $1.19M | 0.02% |
36,320
-2,504
| -6% | -$81.2K |
2018 Q3
12 quarters
|
|
253
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.16M | 0.02% |
+101,921
| New | +$1.4M |
2021 Q3
0 quarters
|
|
|
ANAT
254
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.15M | 0.02% |
6,074
+505
| +9% | +$89.8K |
2021 Q2
1 quarter
|
|
255
Omnicell
OMCL
$1.61B
| $1.14M | 0.02% |
7,638
+68
| +0.9% | +$10.4K |
2021 Q2
1 quarter
|
|
256
Merck
MRK
$364B
| $1.13M | 0.02% |
15,063
+2,394
| +19% | +$182K |
2019 Q2
9 quarters
|
|
257
Red Rock Resorts
RRR
$2.92B
| $1.12M | 0.02% |
+21,651
| New | +$945K |
2021 Q3
0 quarters
|
|
258
Oramed Pharmaceuticals
ORMP
$174M
| $1.11M | 0.02% |
49,924
-3,440
| -6% | -$58.6K |
2021 Q2
1 quarter
|
|
259
CEVA Inc
CEVA
$827M
| $1.11M | 0.02% |
26,516
-1,828
| -6% | -$82.9K |
2017 Q2
17 quarters
|
|
260
Gartner
IT
$12.4B
| $1.1M | 0.02% |
3,564
+274
| +8% | +$79.4K |
2021 Q2
1 quarter
|
|
261
Sunstone Hotel Investors
SHO
$2.14B
| $1.09M | 0.02% |
+89,257
| New | +$1.04M |
2021 Q3
0 quarters
|
|
|
XLNX
262
DELISTED
Xilinx Inc
XLNX
| $1.08M | 0.02% |
7,311
+2,463
| +51% | +$361K |
2017 Q2
17 quarters
|
|
263
Dropbox
DBX
$7.7B
| $1.08M | 0.02% |
36,987
-1,379
| -4% | -$42.8K |
2020 Q2
5 quarters
|
|
264
Bristol-Myers Squibb
BMY
$121B
| $1.08M | 0.02% |
17,964
+2,889
| +19% | +$190K |
2017 Q2
17 quarters
|
|
265
Herc Holdings
HRI
$4.12B
| $1.07M | 0.02% |
6,423
+495
| +8% | +$62.7K |
2021 Q2
1 quarter
|
|
266
Nano X Imaging
NNOX
$40.3M
| $1.05M | 0.02% |
46,168
-3,184
| -6% | -$83.6K |
2020 Q4
3 quarters
|
|
|
HSKA
267
DELISTED
Heska Corp
HSKA
| $1.03M | 0.02% |
+4,037
| New | +$1.03M |
2021 Q3
0 quarters
|
|
268
Thermo Fisher Scientific
TMO
$250B
| $1.02M | 0.02% |
+1,758
| New | +$965K |
2021 Q3
0 quarters
|
|
269
Emergent Biosolutions
EBS
$355M
| $1.01M | 0.02% |
19,546
+3,741
| +24% | +$227K |
2020 Q2
5 quarters
|
|
270
West Pharmaceutical
WST
$26.6B
| $999K | 0.02% |
2,310
-3,856
| -63% | -$1.63M |
2021 Q2
1 quarter
|
|
271
Artisan Partners
APAM
$2.25B
| $995K | 0.02% |
+19,933
| New | +$1.01M |
2021 Q3
0 quarters
|
|
272
AMN Healthcare
AMN
$1.45B
| $990K | 0.02% |
8,830
+679
| +8% | +$72K |
2017 Q2
17 quarters
|
|
273
Highwoods Properties
HIW
$3.15B
| $986K | 0.02% |
+21,818
| New | +$999K |
2021 Q3
0 quarters
|
|
274
Atea Pharmaceuticals
AVIR
$373M
| $971K | 0.02% |
30,225
+5,822
| +24% | +$161K |
2020 Q4
3 quarters
|
|
|
UMPQ
275
DELISTED
Umpqua Holdings Corp
UMPQ
| $971K | 0.02% |
+47,281
| New | +$906K |
2021 Q3
0 quarters
|
|
Similar funds
AIA
PFM
DKP
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q3 2021 Portfolio in Review
As of Q3 2021, ETF Managers Group held 743 positions worth $5.32B, down 13% from $6.13B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ETF Managers Group's Q3 2021 filing shows 97 new, 366 increased, 207 reduced and 70 closed positions. Its largest new stake was N-able: 3,597,911 shares worth $44.8M. The largest sale was Mandiant, Inc. Common Stock, an estimated $53.4M.
By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 43% a quarter earlier, followed by Materials and Healthcare.
- ETF Managers Group's largest Q3 2021 buy was N-able: 3,597,911 shares worth $44.8M.
- ETF Managers Group added most to ETFMG Sit Ultra Short ETF in Q3 2021, an estimated $49.8M increase.
- ETF Managers Group's biggest Q3 2021 reduction was MAG Silver, cutting an estimated $29.1M.
- ETF Managers Group fully exited Mandiant, Inc. Common Stock in Q3 2021, selling an estimated $53.4M.
- ETF Managers Group's ten largest holdings make up 18% of its $5.32B portfolio in Q3 2021.
- ETF Managers Group opened 97 new positions and closed 70 in Q3 2021.
- ETF Managers Group's portfolio value fell 13% quarter-over-quarter to $5.32B.
Based on ETF Managers Group's 13F filing for Q3 2021, filed 15 Nov 2021.